Even Simple Simon concedes that rescheduling doesn't impact Tilray - or other Canadian cannabis LPs.
Do you know something that he doesn't?
If so, can you explain exactly how rescheduling has an effect on Tilray - or are suggesting that intelligent, informed investors should be getting ready for the change by buying US MSOs.
Please pull up your pants and give an honestvresponse
Post by
Vulcanon Apr 13, 2024 7:47am 25 Views
Post# 35987263
Support
Fda supports DEA for rescheduling from class 1 to class 3.. they see no reason to hold this back... may happen sooner than later.. trump and Biden either or need the votes